Cleveland Biolabs (CBLI) Reports Q2 Loss of $0.50/Share

Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($0.50), versus ($0.17) reported last year.

For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Royal Unibrew reports higher interim first-half profit as margins improve
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance